The fund seeks long term growth.
Name | % Net Assets |
---|---|
Royal Dutch Shell 'B' | 5.1% |
BP | 4.9% |
HSBC | 4.4% |
British American Tobacco | 3.5% |
AstraZeneca | 3.4% |
GlaxoSmithKline | 3.4% |
Vodafone | 3.3% |
Rio Tinto | 3.2% |
Royal Bank of Scotland | 3.0% |
Aviva | 2.9% |
Key | % Net Assets |
---|---|
Royal Dutch Shell 'B' | 5.1% |
BP | 4.9% |
HSBC | 4.4% |
British American Tobacco | 3.5% |
Other | 82.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 176.49p |
Currency | GBP |
Change | 0.32p |
% | 0.18% |
YTD change | 5.31p |
YTD % | 3.10% |
Fund Inception | 09/05/2006 |
---|---|
Fund Manager | SRI Team and Pan-European Equities Team |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research